Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.
复制标题

卵巢癌化学抗性的分子决定因素:对旧难题的新见解。

DOI:
10.1111/j.1749-6632.2012.06734.x
复制
发表时间:
2012-10
影响因子:
5.2
通讯作者:
Tsang BK
Tsang BK
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Ali AY;Farrand L;Kim JY;Byun S;Suh JY;Lee HJ;Tsang BK

文献摘要

参考文献

被引文献

相似文献

卵巢癌是最致命的妇科恶性肿瘤。顺铂及其衍生物是一线化疗药物,其耐药性是卵巢癌治疗成功的主要障碍。了解化疗耐药背后的分子失调对于提高治疗结果很重要。在这里,我们回顾了癌症化疗耐药的两条已确立的途径。P53是调节细胞增殖和凋亡的主要肿瘤抑制因子,其突变在人类恶性肿瘤中是一种常见事件。PI3K/Akt轴是一个关键的致癌通路,通过控制包括P53在内的几个肿瘤抑制因子来调节生存和肿瘤的发生。这些通路之间的相互作用是众所周知的,尽管致癌磷酸酶PPM1D为这种复杂的关系增加了新的一层,并为决定细胞命运的过程提供了新的见解。功能食品化合物作为化疗药物的辅助物抑制PI3K/Akt通路,可能会扭转平衡,有利于细胞凋亡,而不是生存,从而提高治疗效果,减少副作用。
Ovarian cancer is the most lethal gynecological malignancy. Cisplatin and its derivatives are first-line chemotherapeutics, and their resistance is a major hurdle in successful ovarian cancer treatment. Understanding the molecular dysregulation underlying chemoresistance is important for enhancing therapeutic outcome. Here, we review two established pathways in cancer chemoresistance. p53 is a major tumor suppressor regulating proliferation and apoptosis, and its mutation is a frequent event in human malignancies. The PI3K/Akt axis is a key oncogenic pathway regulating survival and tumorigenesis by controlling several tumor suppressors, including p53. The interplay between these pathways is well established, although the oncogenic phosphatase PPM1D adds a new layer to this intricate relationship and provides new insights into the processes determining cell fate. Inhibition of the PI3K/Akt pathway by functional food compounds as an adjunct to chemotherapeutics may tip the balance in favor of apoptosis rather than survival, enhancing therapeutic efficacy, and reducing side effects.
DOI: 10.1016/s0092-8674(00)80595-4
发表时间: 1999-03-19
期刊: CELL
影响因子: 64.5
作者:
Brunet, A;Bonni, A;Greenberg, ME
通讯作者: Greenberg, ME
DOI: 10.1073/pnas.94.12.6048
发表时间: 1997-06-10
影响因子: 11.1
作者:
Fiscella, M;Zhang, HL;Appella, E
通讯作者: Appella, E
DOI: 10.1093/jb/mvn135
发表时间: 2009-01-01
影响因子: 2.7
作者:
Chuman, Yoshiro;Kurihashi, Wataru;Sakaguchi, Kazuyasu
通讯作者: Sakaguchi, Kazuyasu
DOI: 10.1158/0008-5472.can-09-4093
发表时间: 2010-03-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Byun, Sanguine;Lee, Ki Won;Dong, Zigang
通讯作者: Dong, Zigang
DOI: 10.1038/sj.onc.1209251
发表时间: 2006-04-01
期刊: ONCOGENE
影响因子: 8
作者:
Fraser, M;Chan, SL;Tsang, BK
通讯作者: Tsang, BK